B. Metzler seel. Sohn & Co. AG
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1847838
FRANKFURT, 2M
Position in ARWR
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,651,392
+$277,451 QoQ
Shares Held
26,338
+27.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026B. Metzler seel. Sohn & Co. AG holds $257,562,391 across 18 Biotechnology names. ARWR ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
511,036 | $228,198,014 | |
| 2 | INSM |
INSMED Inc
|
39,243 | $6,417,014 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,475 | $2,804,122 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,252 | $2,512,624 | |
| 5 | DNLI |
Denali Therapeutics Inc.
|
112,300 | $2,156,160 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
26,338 | $1,651,392 | |
| 7 | TECH |
BIO-TECHNE Corp
|
31,091 | $1,624,815 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
9,241 | $1,561,913 |
All Filings in ARWR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,651,392 | 26,338 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,373,941 | 20,695 | Shares | Defined | 2026-01-28 | |
| 2024-09-30 | $362,315 | 18,705 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $486,142 | 18,705 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $534,963 | 18,705 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $572,373 | 18,705 | Shares | Defined | 2024-02-13 | |
| 2022-03-31 | $472,225 | 10,268 | Shares | Defined | 2022-05-10 | |
| No filing history on record for this holder in this stock. | ||||||